DNA binding and topoisomerase I poisoning activities of novel disaccharide indolocarbazoles

Molecular Pharmacology

Volumn 62, Issue 5, 2002, Pages 1215-1227

  Facompre, Michaël ^a   Carrasco, Carolina ^a   Colson, Pierre ^b   Houssier, Claude ^b   Chisholm, John D ^c   Van Vranken, David L ^c   Bailly, Christian ^a  

^a INSERM   (France)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DIDEOXY 4 METHYLAMINOXYLOSE; 6 FORMYLAMINO 12,13 DIHYDRO 1,11 DIHYDROXY 5H INDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE 5,7(6H) DIONE 13 GLUCOSIDE; ANTIBIOTIC AGENT; CAMPTOTHECIN; CARBAZOLE DERIVATIVE; DISACCHARIDE; DNA TOPOISOMERASE; INDOLE DERIVATIVE; REBECCAMYCIN; UNCLASSIFIED DRUG;

ARTICLE; CIRCULAR DICHROISM; COMPLEX FORMATION; CYTOTOXICITY; DNA BINDING; DNA CLEAVAGE; DNA FOOTPRINTING; DRUG ISOLATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INTOXICATION; MOLECULAR RECOGNITION; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; CARBAZOLES; CELL CYCLE; CELL DIVISION; CIRCULAR DICHROISM; DISACCHARIDES; DNA; DNA DAMAGE; DNA FOOTPRINTING; DNA TOPOISOMERASES, TYPE I; HUMANS; INDOLES; TUMOR CELLS, CULTURED;

EID: 0036839756     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.62.5.1215     Document Type: Article

References (34)

1. Anizon F, Belin L, Moreau P, Sancelme M, Voldoire A, Prudhomme M, Ollier M, Severe D, Riou JF, Bailly C, et al. (1997) Syntheses and biological activity (topoisomerases inhibition, antitumoral and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group. J Med Chem 40:3456-3465.
2. Arakawa H, Iguchi T, Morita M, Yoshinari T, Kojiri K, Suda H, Okura A, and Nishimura S (1995) Novel indolocarbazole compound 6-N-formylamino-12,13-dihydro-1, 11-dihydroxy-13-(β-D·-glucopyranosyl)-5H-indolo[2, 3-apyrrolo-[3,4-c]carbazole-5,7-(6H)-dione (NB-506): Its potent antitumor activities in mice. Cancer Res 55:1316-1320.
3. Arcamone F, Animati F, Capranico G, Lombardi P, Pratesi G, Manzini S, Supino R, and Zunino F (1997) New developments in antitumor anthracyclines. Pharmacol Ther 76:117-124.
4. Bailly C, Goossens JF, Laine W, Anizon F, Prudhomme M, Ren J, and Chaires JB (2000) Formaldehyde cross-linking of a 2′-aminoglucose rebeccamycin derivative to both A·T and G·C base pairs in DNA. J Med Chem 43:4711-4720.
5. Bailly C, Dassonneville L, Colson P, Houssier C, Fukasawa K, Nishimura S, and Yoshinari T (1999a) Intercalation into DNA is not required for inhibition of topoisomerase I by indolocarbazole antitumor agents. Cancer Res 59:2853-2860.
6. Bailly C, Helbecque N, Hénichart JP, Colson P, Houssier C, Rao KE, Shea RG, and Lown JW (1990) Molecular recognition between oligopeptides and nucleic acids. DNA sequence specificity and binding properties of an acridine-linked netropsin hybrid ligand. J Mol Recognit 3:26-35.
7. Bailly C, Qu X, Chaires JB, Colson P, Houssier C, Ohkubo M, Nishimura S, and Yoshinari T (1999b) Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding and topoisomerase I inhibition activities. J Med Chem 42:2927-2935.
8. Bailly C, Qu X, Graves DE, Prudhomme M, and Chaires JB (1999c) Calories from carbohydrates. Energetic contribution of the carbohydrate moiety of rebeccamycin to DNA binding and the effect of its orientation on topoisomerase I inhibition. Chem Biol 6:277-286.
9. Bailly C (2001) DNA relaxation and cleavage assays to study topoisomerase I inhibitors. Methods Enzymol 340:610-623.
10. Bailly C, Riou JF, Colson P, Houssier C, Rodrigues-Pereira E, and Prudhomme M (1997) DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin. Biochemistry 36:3917-3929.
11. Bailly C and Waring MJ (1995) Comparison of different footprinting methodologies for detecting binding sites for a small ligand on DNA. J Biomol Struct Dyn 12:869-898.
12. Bush JA, Long BH, Catino JJ, Bradner WT, and Tomita K (1987) Production and biological activity of rebeccamycin, a novel antitumor agent. J Antibiot (Tokyo) 40:668-678.
13. Carrasco C, Facompré M, Chisholm JD, Van Vranken DL, Wilson WD, and Bailly C (2002) DNA sequence recognition by the indolocarbazole antitumor antibiotic AT2433-B1 and its diastereoisomer. Nucleic Acids Res 30:1774-0781.
14. Chisholm JD, Golik J, Krishnan B, Matson JA, and Van Vranken DL (1999) A caveat in the application of the exciton chirality method to N,N-dialkyl amides. Synthesis and structural revision of AT2433-B1. J Am Chem Soc 121:3801-3802.
15. Chisholm JD and Van Vranken DL (2000) Regiocontrolled synthesis of the antitumor antibiotic AT2433-A1. J Org Chem 65:7541-7553.
16. Colson P, Bailly C, and Houssier C (1996) Electric linear dichroism as a new tool to study sequence preference in drug binding to DNA. Biophys Chem 58:125-140.
17. Davis TM and Wilson WD (2000) Determination of the refractive index increments of small molecules for correction of surface plasmon resonance data. Anal Biochem 284:348-353.
18. Fujimori A, Harker WG, Kohlhagen G, Hoki Y, and Pommier Y (1995) Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell line resistant to camptothecin. Cancer Res 55:1339-1346.
19. Golik J, Doyle TW, Krishnan B, Dubay G, and Matson JA (1989) AT2433-A1, AT2433-A2, AT2433-B1 and AT2433-B2 novel antitumor compounds produced by Actinomadura melliaura. II. Structure determination. J Antibiot (Tokyo) 42:1784-1789.
20. Guano F, Pourquier P, Tinelli S, Binaschi M, Bigioni M, Animati F, Manzini S, Zunino F, Kohlhagen G, Pommier Y, et al. (1999) Topoisomerase poisoning activity of novel disaccharide anthracyclines. Mol Pharmacol 67:77-84.
21. Hagmar P, Marquet R, Colson P, Kubista M, Nielsen P, Norden B, and Houssier C (1989) Electric and flow linear dichroism of unfolded and condensed chromatin: A comparative study at low and intermediate ionic strength. J Biomol Struct Dyn 7:19-33.
22. Houssier C (1981) Investigating nucleic acids, nucleoproteins, polynucleotides and their interactions with small ligands by electro-optical systems, in Molecular Electro-Optics (Krause S ed.) pp. 363-398, Plenum Press, New York.
23. Kanzawa F, Nishio K, Kubota N, and Saijo N (1995) Antitumor activities of a new indolocarbazole substance, NB-506 and establishment of NB-506-resistant cell lines, SBC-3/NB. Cancer Res 55:2806-2813.
24. Kluza J, Lansiaux A, Wattez N, Mahieu C, Osheroff N, and Bailly C (2000) Apoptotic response of HL-60 human leukemia cells to the antitumor drug TAS-103. Cancer Res 60:4077-4084.
25. Komatani H, Morita M, Sakaizumi N, Fukasawa K, Yoshida E, Okura A, Yoshinari T, and Nishimura S (1999) A new mechanism of acquisition of drug resistance by partial duplication of topoisomerase I. Cancer Res 59:2701-2708.
26. Matson JA, Claridge C, Bush JA, Titus J, Bradner WT, Doyle TW, Horan AC, and Patel M (1989) AT2433-A1, AT2433-A2, AT2433-B1 and AT2433-B2, novel antitumor antibiotic compounds produced by Actinomadura malliaura. J Antibiot (Tokyo) 42:1547-1555.
27. Nettleton DE, Doyle TW, Krishnan B, Matsumoto GK, and Clardy J (1985) Isolation and structure of rebeccamycin: A new antitumor antibiotic from Nocardia aerocolonigenes. Tetrahedron Lett 26:4011-4014.
28. Nitiss JL, Pourquier P, and Pommier Y (1997) Aclacinomycin A stabilizes topoisomerase I covalent complexes. Cancer Res 57:4564-4569.
29. Pommier Y, Pourquier P, Urasaki Y, Wu J, and Laco GS (1999) Topoisomerase I inhibitors: Selectivity and cellular resistance. Drug Resist Updat 2:307-318.
30. Qu X, Chaires JB, Ohkubo M, Yoshinari T, Nishimura S, and Bailly C (2000) A DNA-binding indolocarbazole disaccharide derivative remains highly cytotoxic without inhibiting topoisomerase I. Anticancer Drug Des 14:433-442.
31. Sim SP, Gatto B, Yu C, Liu AA, Li TK, Pilch DS, LaVoie EJ, and Liu LF (1997) Differential poisoning of topoisomerases by menogaril and nogalamycin dictated by the minor groove-binding nogalose sugar. Biochemistry 36:13285-13291.
32. Urasaki Y, Laco G, Takebayashi Y, Bailly C, Kohlhagen G, and Pommier Y (2001) Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506 and its topoisomerase I binding site. Cancer Res 61:504-508.
33. Woo MH, Vance JR, Otero Marcos AR, Bailly C, and Bjornsti M-A (2002) Active site mutations in DNA topoisomerase I distinguish the cytotoxic activities of camptothecin of camptothecin and the indolocarbazole, rebeccamycin. J Biol Chem 277:3813-3822.
34. Yoshinari T, Matsumoto M, Arakawa H, Okada H, Noguchi K, Suda H, Okura A, and Nishimura S (1995) Novel antitumor indolocarbazole compound 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13-(βmiddot; -D-glucopyranosyl)-5H-indolo-[2,3-a]pyrrolo-[3,4·c]carbazole-5, 7-(6H)-dione (NB-506): Induction of topoisomerase I-mediated DNA cleavage and mechanisms of cell line-selective cytotoxicity. Cancer Res 55:1310-1315.